Bioassay protocol for in vitro determination of sea lice sensitivity to emamectin benzoate (PDF 78kb)
Bioassays are an important tool for determining the sensitivity of sea lice to treatments. They can be used routinely throughout the growing cycle to help predict the sensitivity of sea lice to available treatments or to detect changes in sensitivity within a population of sea lice...
Guidelines for sampling of feed medicated with SLICE® (emamectin benzoate) (PDF 91kb)
Proper manufacture of medicated feeds and administration of the correct dosage are essential to help ensure successful treatment of fish, prevent sub-optimal drug delivery and
minimize pressure for the selection of resistance.
Best-practice treatment principles: Sea lice resistance management (PDF 153kb)
In September 2000, MSD Animal Health published a technical bulletin entitled Sea Lice Resistance Management (with particular reference to avermectins)...
Stability of emamectin benzoate in methanol stock solution at three different temperatures (PDF 75kb)
Bioassays are increasingly being used as a tool to predict sensitivity or to detect changes in sensitivity of sea lice to available sea lice treatments; methods are available for conducting bioassays with pyrethroids (deltamethrin [Alphamax®] and cypermethrin [Excis®]), azimethiphos [Salmosan®] and emamectin benzoate [SLICE®]...
Monitoring results with SLICE® at a Scottish salmon farm (PDF 151kb)
In 2010, MSD Animal Health launched the SLICE® Sustainability Project (SSP), a program designed to help the global salmon industry develop sustainable sea lice control programs. The project accomplishes this by providing support to salmon producers, by utilizing proven management practices and by focusing on four core actions — Protect, Conserve, Review and Succeed.
Improved SLICE® medicated-feed assay method (PDF 109kb)
SLICE® (emamectin benzoate, 0.2% w/w) medicated premix is a parasiticide indicated
for the treatment and prevention of sea lice infestations in salmonids. Preformed fish pellets
are top-coated with the premix, and then an overcoat of fish oil is applied to ensure even distribution of the premix on pellets.
Standard operating procedure: flesh testing after SLICE® treatment (PDF 116kb)
The SLICE® Sustainability Project (SSP), launched by MSD Animal Health in 2010, is designed to help the global salmon industry develop sustainable sea lice control programs including SLICE®. SLICE (emamectin benzoate) is a highly effective, medicated feed premix indicated for the treatment and prevention of all parasitic stages of sea lice on salmon.